Privium Fund Management’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.86M Buy
5,467,149
+109,387
+2% +$179K 1.84% 17
2025
Q4
$10.8M Buy
5,357,762
+359,475
+7% +$840K 1.99% 14
2025
Q3
$10.6M Buy
4,998,287
+725
+0% +$1.58K 1.91% 12
2025
Q2
$10M Buy
4,997,562
+11,929
+0.2% +$19.4K 2.17% 10
2025
Q1
$6.63M Hold
4,985,633
1.73% 13
2024
Q4
$13.2M Sell
4,985,633
-646,755
-11% -$2.05M 2.99% 7
2024
Q3
$10.3M Buy
5,632,388
+51,663
+0.9% +$97K 2.55% 10
2024
Q2
$9.21M Buy
5,580,725
+236,279
+4% +$459K 2.35% 11
2024
Q1
$12.2M Hold
5,344,446
3.27% 7
2023
Q4
$11.1M Hold
5,344,446
3.1% 8
2023
Q3
$6.95M Hold
5,344,446
2.07% 14
2023
Q2
$8.66M Hold
5,344,446
2.49% 15
2023
Q1
$11.4M Hold
5,344,446
3.82% 6
2022
Q4
$18M Hold
5,344,446
6.83% 4
2022
Q3
$4.04M Hold
5,344,446
1.53% 22
2022
Q2
$4.16M Buy
5,344,446
+100,000
+2% +$74.5K 1.41% 23
2022
Q1
$4.75M Buy
5,244,446
+478,787
+10% +$1.6M 1.07% 26
2021
Q4
$38.9M Buy
+4,765,659
New +$36.3M 7.76% 2

Other funds holding PRQR